Sign in Subscribe
COVID-19 vaccines

Philippines Joins Mexico and Hungary in Having the Most EUA for Covid-19 Vaccines

Strategic Insights

— 1 min read

The Philippines has matched Mexico and Hungary's record by issuing six Emergency Use Authorizations (EUAs) for Covid-19 vaccines. According to FDA Director General Eric Domingo, the country has similarly authorized six Covid-19 vaccines, including those from Pfizer-Biontech, AstraZeneca, Gamaleya Research Institute of Epidemiology, and Sinovac Biotech. Despite concerns about blood clots associated with the Johnson and Johnson vaccine, the FDA maintains that the benefits of using these vaccines outweigh the risks. The move aims to increase the supply of Covid-19 vaccines in the country.

Key Takeaways:

  • The Philippines has joined Mexico and Hungary in having the most EUAs for Covid-19 vaccines, with a total of six EUAs issued.
  • The authorized Covid-19 vaccines include Pfizer-Biontech, AstraZeneca, Gamaleya Research Institute of Epidemiology, and Sinovac Biotech.
  • The FDA issued a 'conditional' EUA to Bharat Biotech and a regular EUA to Johnson and Johnson for their respective Covid-19 vaccines.
  • The FDA has recommended clear guidelines to inform those who will be vaccinated about blood clot symptoms for the Johnson and Johnson vaccine.
  • The FDA may standardize the guidelines for jabs based on adenoviral vectors, including those from AstraZeneca and Gamaleya.
  • The EUAs will allow the government to tap more manufacturers to supply the country with needed Covid-19 vaccine doses.
  • The FDA maintains its position that the benefits of using the six Covid-19 vaccines with EUA outweigh the potential risk to recipients.

Statistics:

  • 6 EUAs issued for Covid-19 vaccines in the Philippines, matching Mexico and Hungary's record.
  • 8 EUAs issued to 8 Covid-19 vaccine manufacturers in Hungary.
  • Adams, Sinovac, and Pfizer-Biontech, and AstraZeneca, and Gamaleya Research Institute of Epidemiology have EUA for Covid-19 vaccine in the Philippines.
  • 1 in every million recipients of the Covid-19 vaccine of Johnson and Johnson may experience blood clots.
  • The total number of EUAs issued for Covid-19 vaccines worldwide is not specified in the article.

Sources:

  • Interview with PTV by FDA Director General Eric Domingo
  • Food and Drug Administration (FDA)

Read more